Spiden Company

Spiden is a medical technology company that develops optical and AI-based technology to analyze body fluids non-destructively and in real-time. Their goal is to achieve continuous, non-invasive, and medical-grade multi-biomarker monitoring through a next-generation wearable device, starting with glucose monitoring. Spiden's products aim to optimize treatment and increase safety for critical and high-risk patients. They were founded in 2019 and have received a grant in 2022.

Headquarters: Freienbach, Schwyz, Switzerland
Industry: Aging Biomarkers
Employee Number: 11-50
Investors Number: 8
Funding Status: Seed
Number Of Exists: 11-50
Last Funding Type: Seed
Founded Date: 2017
Total Funding: 25250000
Last Funding Date: 2021-04-29